TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors Meeting Abstract
| Authors: | Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arena, S.; Mussolin, B.; Kannan, R.; Vasan, N.; Gorelick, A. N.; Berger, M. F.; Liao, Y.; Rix, U.; Bardelli, A.; Hechtman, J.; de Stanchina, E.; Hyman, D. M.; Verma, C.; Ventura, A.; Drilon, A.; Scaltriti, M. |
| Abstract Title: | TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors |
| Meeting Title: | 111th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 80 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2020 Apr 27-28/Jun 22-24 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2020-08-01 |
| Language: | English |
| ACCESSION: | WOS:000590059301475 |
| DOI: | 10.1158/1538-7445.Am2020-5680 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5680 -- Due to COVID-19 pandemic, the conference was held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
